Karl-Philipp Rommel1, Hadeel Badarnih1, Steffen Desch2, Matthias Gutberlet3, Gerhard Schuler1, Holger Thiele2, Ingo Eitel4. 1. Department of Internal Medicine/Cardiology, University of Leipzig-Heart Center, Leipzig, Germany. 2. Department of Internal Medicine/Cardiology, University of Leipzig-Heart Center, Leipzig, Germany University Heart Center Lübeck, Medical Clinic II (Cardiology, Angiology, Intensive Care Medicine), Ratzeburger Allee 160, 23538 Lübeck, Germany. 3. Department of Diagnostic/Interventional Radiology, University of Leipzig-Heart Center, Leipzig, Germany. 4. Department of Internal Medicine/Cardiology, University of Leipzig-Heart Center, Leipzig, Germany University Heart Center Lübeck, Medical Clinic II (Cardiology, Angiology, Intensive Care Medicine), Ratzeburger Allee 160, 23538 Lübeck, Germany ingoeitel@gmx.de.
Abstract
AIMS: Distortion of the terminal portion of the QRS complex (so-called Grade 3 ischaemia, G3I) has been associated with adverse outcomes in ST-elevation myocardial infarction (STEMI) populations. However, the correlation of G3I with infarct size and microvascular injury as defined by cardiac magnetic resonance (CMR) is not well defined. Aim of this study was to assess the relation of G3I with myocardial damage as assessed by CMR and clinical outcomes in STEMI patients. METHODS AND RESULTS: We analysed the ECGs of 572 consecutive STEMI patients regarding the presence or absence of G3I. CMR was performed within 1 week after infarction for comprehensive assessment of myocardial damage using a standardized protocol. The primary clinical endpoint was major adverse cardiac events (MACE) within 12 months after infarction. G3I was present in 186 (32%) patients. The presence of G3I was associated with larger infarct size (P = 0.01), the presence of late microvascular obstruction (P = 0.05), the presence of intramyocardial haemorrhage (P = 0.04), and impaired myocardial salvage (P = 0.01). G3I was associated with a higher incidence of MACE (P = 0.01) and was identified as an independent predictor of MACE in Cox regression analysis (HR 2.19; 95% CI 1.10 to 4.38, P = 0.03). CONCLUSION: This largest study to date correlating G3I on the admission ECG with CMR markers of myocardial damage demonstrates that G3I is significantly associated with infarct size, impaired myocardial salvage, and reperfusion injury in a reperfused STEMI population. Moreover, G3I was independently associated with MACE. CLINICALTRIALS.GOV: NCT00712101. Published on behalf of the European Society of Cardiology. All rights reserved.
RCT Entities:
AIMS: Distortion of the terminal portion of the QRS complex (so-called Grade 3 ischaemia, G3I) has been associated with adverse outcomes in ST-elevation myocardial infarction (STEMI) populations. However, the correlation of G3I with infarct size and microvascular injury as defined by cardiac magnetic resonance (CMR) is not well defined. Aim of this study was to assess the relation of G3I with myocardial damage as assessed by CMR and clinical outcomes in STEMI patients. METHODS AND RESULTS: We analysed the ECGs of 572 consecutive STEMI patients regarding the presence or absence of G3I. CMR was performed within 1 week after infarction for comprehensive assessment of myocardial damage using a standardized protocol. The primary clinical endpoint was major adverse cardiac events (MACE) within 12 months after infarction. G3I was present in 186 (32%) patients. The presence of G3I was associated with larger infarct size (P = 0.01), the presence of late microvascular obstruction (P = 0.05), the presence of intramyocardial haemorrhage (P = 0.04), and impaired myocardial salvage (P = 0.01). G3I was associated with a higher incidence of MACE (P = 0.01) and was identified as an independent predictor of MACE in Cox regression analysis (HR 2.19; 95% CI 1.10 to 4.38, P = 0.03). CONCLUSION: This largest study to date correlating G3I on the admission ECG with CMR markers of myocardial damage demonstrates that G3I is significantly associated with infarct size, impaired myocardial salvage, and reperfusion injury in a reperfused STEMI population. Moreover, G3I was independently associated with MACE. CLINICALTRIALS.GOV: NCT00712101. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Therese Billgren; Charles Maynard; Timothy F Christian; Mohmmad A Rahman; Mahammad Saeed; Stephen C Hammill; Galen S Wagner; Yochai Birnbaum Journal: J Electrocardiol Date: 2005-07 Impact factor: 1.438
Authors: Sorin J Brener; Roxana Mehran; Bruce R Brodie; Giulio Guagliumi; Bernhard Witzenbichler; Ecaterina Cristea; Ke Xu; Alexandra J Lansky; Gregg W Stone Journal: Am J Cardiol Date: 2011-07-20 Impact factor: 2.778
Authors: James C Weaver; David Rees; Ananth M Prasan; David D Ramsay; Maurits F Binnekamp; Jane A McCrohon Journal: J Electrocardiol Date: 2011 Jan-Feb Impact factor: 1.438
Authors: Yochai Birnbaum; Kenneth W Mahaffey; Douglas A Criger; Kathy B Gates; Gabriel I Barbash; Alejandro Barbagelata; Peter Clemmensen; Elena B Sgarbossa; Raymond J Gibbons; M Atiar Rahman; Robert M Califf; Chistopher B Granger; Galen S Wagner Journal: Cardiology Date: 2002 Impact factor: 1.869
Authors: Y Birnbaum; I Herz; S Sclarovsky; B Zlotikamien; A Chetrit; L Olmer; G I Barbash Journal: J Am Coll Cardiol Date: 1996-04 Impact factor: 24.094
Authors: Christopher E Buller; Yuling Fu; Kenneth W Mahaffey; Thomas G Todaro; Peter Adams; Cynthia M Westerhout; Harvey D White; Arnoud W J van 't Hof; Frans J Van de Werf; Galen S Wagner; Christopher B Granger; Paul W Armstrong Journal: Circulation Date: 2008-09-08 Impact factor: 29.690
Authors: Jakob Almer; Viktor Elmberg; Josef Bränsvik; David Nordlund; Ardavan Khoshnood; Michael Ringborn; Marcus Carlsson; Ulf Ekelund; Henrik Engblom Journal: Ann Noninvasive Electrocardiol Date: 2018-09-28 Impact factor: 1.468
Authors: Christina Tiller; Magdalena Holzknecht; Martin Reindl; Ivan Lechner; Verena Kalles; Felix Troger; Johannes Schwaiger; Agnes Mayr; Gert Klug; Christoph Brenner; Axel Bauer; Bernhard Metzler; Sebastian Johannes Reinstadler Journal: Open Heart Date: 2021-02